Genetic dysbiosis: The role of microbial insults in chronic inflammatory diseases

Journal of Oral Microbiology

Volumn 6, Issue 1, 2014, Pages

  Nibali, Luigi ^a   Henderson, Brian ^a   Sadiq, Syed Tariq ^b   Donos, Nikos ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Dysbiosis; Genetic; Inflammation; Microbiome

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL GROWTH; BIOFILM; CHRONIC INFLAMMATORY DISEASE; GENETIC ASSOCIATION; GENETIC DYSBIOSIS; GENETIC RISK; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; MICROBIOME; MICROFLORA; MOLECULAR GENETICS; MOLECULAR RECOGNITION; NONHUMAN; PERIODONTAL DISEASE; PSORIASIS; REVIEW; VAGINITIS;

EID: 84903479539     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v6.22962     Document Type: Review

References (114)

1. McFall-Ngai M, Henderson B, Ruby N, editors. The influence of cooperative bacteria on animal host biology. New York: Cambridge University Press; 2005.
2. Ruby E, Henderson B, McFall-Ngai M. Microbiology-we get by with a little help from our (little) friends. Science. 2004; 303: 1305-7.
3. Wilson M. Bacterial inhabitants of humans: their ecology and role in health and disease. New York: Cambridge University Press; 2005.
4. Wu GD, Lewis JD. Analysis of the human gut microbiome and association with disease. Clin Gastroenterol Hepatol. 2013; 7: 774-7.
5. Wilson M. Bacteriology of humans: an ecological perspective. Oxford: Blackwell; 2008.
6. Handelsman J. Metagenomics: application of genomics to uncultured microorganisms. Microbiol Mol Biol Rev. 2004; 68: 669-85.
7. Petrosino JF, Highlander S, Luna RA, Gibbs RA, Versalovic J. Metagenomic pyrosequencing and microbial identification. Clin Chem. 2009; 55: 856-66.
8. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. Highthroughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008; 57: 1605-15.
9. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486: 207-14.
10. Benedek TG. The history of bacteriologic concepts of rheumatic fever and rheumatoid arthritis. Semin Arthritis Rheum. 2006; 36: 109-23.
11. Detert J, Pischon N, Burmester GR, Buttgereit F. The association between rheumatoid arthritis and periodontal disease. Arthritis Res Ther. 2010; 12: 218.
12. De Pablo P, Dietrich T, Chapple IL, Milward M, Chowdhury M, Charles PJ, et al. The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Ann Rheum Dis 2014; 73(3): 580-6.
13. Makris GC, Makris MC, Wilmot VV, Geroulakos G, Falagas ME. The role of infection in carotid plaque pathogenesis and stability: the clinical evidence. Curr Vasc Pharmacol. 2010; 8: 861-72.
14. Taylor GS, Blackbourn DJ. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV. Cancer Lett. 2011; 305: 263-78.
15. Piazuelo MB, Epplein M, Correa P. Gastric cancer: an infectious disease. Infect Dis Clin North Am. 2010; 24: 853-69.
16. Sun J. Enteric bacteria and cancer stem cells. Cancers (Basel). 2010; 3: 285-97.
17. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012; 13: F12-23.
18. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007; 370: 890-907.
19. Balkwill F, Mantovani A. Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Therapeut. 2010; 87: 401-6.
20. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A. 2010; 107: 11537-42.
21. Arthur JC, Jobin C. The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis. 2011; 17: 396-409.
22. Ge ZM, Rogers AB, Feng Y, Lee A, Xu S, Taylor NS, et al. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol. 2007; 9: 2070-80.
23. Socransky SS, Haffajee AD, Smith C, Duff GW. Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. J Clin Periodontol. 2000; 27: 810-18.
24. Hay P. How important are the newly described bacteria in bacterial vaginosis? Sex Transm Infect 2009; 85: 240-1.
25. Gao Z, Tseng CH, Strober BE, Pei ZH, Blaser MJ. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One. 2008; 3: e2719.
26. Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol. 2011; 8: 152-68.
27. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006; 124: 823-35.
28. Floch MH, Madsen KK, Jenkins DJA, Guandalini S, Katz JA, Onderdonk A, et al. Recommendations for probiotic use. J Clin Gastroenterol. 2006; 40: 275-8.
29. Brito F, de Barros FC, Zaltman C, Carvalho AT, Carneiro AJ, Fischer RG, et al. Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. J Clin Periodontol. 2008; 35: 555-60.
30. Srinivasan U, Misra D, Marazita ML, Foxman B. Vaginal and oral microbes, host genotype and preterm birth. Med Hypotheses. 2009; 73: 963-75.
31. Preus HR, Khanifam P, Kolltveit K, Mork C, Gjermo P. Periodontitis in psoriasis patients. A blinded, case-controlled study. Acta Odontol Scand. 2010; 68: 165-70.
32. Sanu O, Lamont RF. Periodontal disease and bacterial vaginosis as genetic and environmental markers for the risk of spontaneous preterm labor and preterm birth. J Matern Fetal Neonatal Med. 2011; 24: 1476-85.
33. Figueredo CM, Brito F, Barros FC, Menegat JS, Pedreira RR, Fischer RG, et al. Expression of cytokines in the gingival crevicular fluid and serum from patients with inflammatory bowel disease and untreated chronic periodontitis. J Periodontal Res. 2011; 46: 141-6.
34. Indriolo A, Greco S, Ravelli P, Fagiuoli S. What can we learn about biofilm/host interactions from the study of inflammatory bowel disease. J Clin Periodontol. 2011; 38: 36-43.
35. Binus AM, Han J, Qamar AA, Mody EA, Holt EW, Qureshi AA. Associated comorbidities in psoriasis and inflammatory bowel disease. J Eur Acad Dermatol Venereol. 2012; 26: 644-50.
36. Fry L, Baker BS, Powles AV, Fahlen A, Engstrand L. Is chronic plaque psoriasis triggered by microbiota in the skin? Br J Dermatol 2013; 169: 47-52.
37. Kellam P, Weiss RA. Infectogenomics: insights from the host genome into infectious diseases. Cell. 2006; 124: 695-7.
38. Janeway CA. Approaching the asymptote-evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 1989; 54: 1-13.
39. Dagenais M, Dupaul-Chicoine J, Saleh M. Function of NODlike receptors in immunity and disease. Curr Opin Investig Drugs. 2010; 11: 1246-55.
40. Hansen JD, Vojtech LN, Laing KJ. Sensing disease and danger: a survey of vertebrate PRRs and their origins. Dev Comp Immunol. 2011; 35: 886-97.
41. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011; 30: 16-34.
42. Nibali L, Ready DR, Parkar M, Brett PM, Wilson M, Tonetti MS, et al. Gene polymorphisms and the prevalence of key periodontal pathogens. J Dent Res. 2007; 86: 416-20.
43. Genc MR, Vardhana S, Delaney ML, Onderdonk A, Tuomala R, Norwitz E, et al. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol. 2004; 116: 152-6.
44. Verstraelen H, Verhelst R, Nuytinck L, Roelens K, De Meester E, De Vos D, et al. Gene polymorphisms of toll-like and related recognition receptors relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae. J Reprod Immunol. 2009; 79: 163-73.
45. Divaris K, Monda KL, North KE, Olshan AF, Lange EM, Moss K, et al. Genome-wide association study of periodontal pathogen colonization. J Dent Res 2012; 91 (7 Suppl): 21S-8S.
46. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011; 6: e16393.
47. Alonso VR, Guarner F. Linking the gut microbiota to human health. Br J Nutr. 2013; 109: S21-6.
48. Frank DN, Amand ALS, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104: 13780-5.
49. Isaacs KL, Sartor RB. Treatment of inflammatory bowel disease with antibiotics. Gastroenterol Clin North Am. 2004; 33: 335-45.
50. Parkes M. Evidence from genetics for a role of autophagy and innate immunity in IBD pathogenesis. Dig Dis. 2012; 30: 330-3.
51. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol. 2006; 55: 1141-9.
52. Chow J, Mazmanian SK. A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe. 2010; 7: 265-76.
53. Inohara N, Chamaillard M, McDonald C, Nunez G. NODLRR proteins: role in host-microbial interactions and inflammatory disease. Ann Rev Biochem. 2005; 74: 355-83.
54. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411: 603-6.
55. Sun LL, Nava GM, Stappenbeck TS. Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease. Curr Opin Gastroenterol. 2011; 27: 321-7.
56. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491: 119-24.
57. Craven M, Egan CE, Dowd SE, McDonough SP, Dogan B, Denkers EY, et al. Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS One. 2012; 7: e41594.
58. Roberson EDO, Bowcock AM. Psoriasis genetics: breaking the barrier. Trends Genet. 2010; 26: 415-23.
59. Norrlind R. The significance of infections in the origination of psoriasis. Acta Rheumatol Scand. 1955; 1: 135-44.
60. Tervaert WC, Esseveld H. A study of incidence of haemolytic streptococci in throat in patients with psoriasis vulgaris, with reference to their role in pathogenesis of this disease. Dermatologica. 1970; 140: 282-90.
61. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol. 2003; 149: 530-4.
62. Fahlen A, Engstrand L, Baker BS, Powles A, Fry L. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res. 2012; 304: 15-22.
63. Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL. The microbiome extends to subepidermal compartments of normal skin. Nat Commun. 2013; 4: 1431.
64. Chamian F, Lowes MA, Lin SL, Lee E, Kikuchi T, Gilleaudeau P, et al. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci U S A. 2005; 102: 2075-80.
65. Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, Nussbaum R, et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci U S A. 2005; 102: 19057-62.
66. Bataille V, Lens M, Spector TD. The use of the twin model to investigate the genetics and epigenetics of skin diseases with genomic, transcriptomic and methylation data. J Eur Acad Dermatol Venereol. 2012; 26: 1067-73.
67. Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet. 1997; 6: 813-20.
68. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV,Westphal E, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000; 66: 1833-44.
69. Tsoi LC, Spain SL, Knight J, Ellinghaus S, Stuart PE, Capon F, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet. 2012; 44: 1341-8.
70. Oka A, Mabuchi T, Ozawa A, Inoko H. Current understanding of human genetics and genetic analysis of psoriasis. J Dermatol. 2012; 39: 231-41.
71. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999; 4: 1-6.
72. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontology. 2000; 14: 216-48.
73. Rylev M, Kilian M. Prevalence and distribution of principal periodontal pathogens worldwide. J Clin Periodontol. 2008; 35: 346-61.
74. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012; 91: 914-20.
75. American Academy of Periodontology. Epidemiology of periodontal diseases. J Periodontol. 1996; 67: 935-45.
76. Socransky S, Haffajee A. Periodontal infections. In: Lindhe J, Lang N, Karring P eds. Clinical implantology and implant dentistry. Oxford, UK: Blackwell Munksgaard; 2012; 207-267.
77. Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol. 2006; 33: 401-7.
78. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000; 71: 1554-60.
79. Leon R, Silva N, Ovalle A, Chaparro A, Ahumada A, Gajardo M, et al. Detection of Porphyromonas gingivalis in the amniotic fluid in pregnant women with a diagnosis of threatened premature labor. J Periodontol. 2007; 78: 1249-55.
80. Quirke AM, Lugli EB, Wegner N, Hamilton BC, Charles P, Chowdhury M, et al. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis. 2014; 73: 263-9.
81. Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ. Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis. 2008; 13: 437-49.
82. Stein PS, Steffen MJ, Smith C, Jicha G, Ebersole JL, Abner E, et al. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement. 2012; 8: 196-203.
83. Socransky SS, Haffajee AD. Microbial mechanisms in the pathogenesis of destructive periodontal-diseases-a critical assessment. J Periodontal Res. 1991; 26: 195-212.
84. Nibali L, Tonetti MS, Ready D, Parkar M, Brett PM, Donos N, et al. Interleukin-6 polymorphisms are associated with pathogenic bacteria in subjects with periodontitis. J Periodontol. 2008; 79: 677-83.
85. Nibali L, Madden I, Chillida FF, Heitz-Mayfield LJA, Brett PM, Donos N. IL6-174 genotype associated with Aggregatibacter actinomycetemcomitans in Indians. Oral Dis. 2011; 17: 232-7.
86. Nibali L, Donos N, Henderson B. Periodontal infectogenomics. J Med Microbiol. 2009; 58: 1269-74.
87. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet. 2003; 361: 983-8.
88. Spiegel CA. Bacterial vaginosis. Clin Microbiol Rev. 1991; 4: 485-502.
89. Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C, et al. The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One. 2013; 8: e74378.
90. Forsum U, Holst E, Larsson PG, Vasquez A, Jakobsson T, Mattsby-Baltzer I. Bacterial vaginosis-a microbiological and immunological enigma. Apmis. 2005; 113: 81-90.
91. Turovskiy Y, Noll KS, Chikindas ML. The aetiology of bacterial vaginosis. J Appl Microbiol. 2011; 110: 1105-28.
92. Matu MN, Orinda GO, Njagi EN, Cohen CR, Bukusi EA. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Anaerobe. 2010; 16: 210-15.
93. Hay P. Life in the littoral zone: lactobacilli losing the plot. Sex Transm Infect. 2005; 81: 100-2.
94. Mattozzi C, Richetta AG, Cantisani C, Macaluso L, Calvieri S. Psoriasis: new insight about pathogenesis, role of barrier organ integrity, NLR/CATERPILLER family genes and microbial flora. J Dermatol. 2012; 39: 752-60.
95. Keller JJ, Lin HC. The effects of chronic periodontitis and its treatment on the subsequent risk of psoriasis. Br J Dermatol. 2012; 167: 1338-44.
96. Li WQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women. Ann Rheum Dis. 2013; 72: 1200-5.
97. Persson R, Hitti J, Verhelst R, Vaneechoutte M, Persson R, Hirschi R, et al. The vaginal microflora in relation to gingivitis. BMC Infect Dis. 2009; 9: 6.
98. Henckaerts L, Pierik M, Joossens M, Ferrante M, Rutgeerts P, Vermeire S. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut. 2007; 56: 1536-42.
99. Genc MR, Schantz-Dunn J. The role of gene-environment interaction in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007; 21: 491-504.
100. Schulz S, Zissler N, Altermann W, Klapproth J, Zimmermann U, Glaser C, et al. Impact of genetic variants of CD14 and TLR4 on subgingival periodontopathogens. Int J Immunogenet. 2008; 35: 457-64.
101. Cauci S, Di Santolo M, Casabellata G, Ryckman K, Williams SM, Guaschino S. Association of interleukin-1 beta and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women. Mol Hum Reprod. 2007; 13: 243-50.
102. Havemose-Poulsen A, Sorensen LK, Bendtzen K, Holmstrup P. Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol. 2007; 78: 475-92.
103. Queiroz DMM, Oliveira AG, Saraiva IEB, Rocha GA, Rocha AM, das Gracas Pimenta Sanna M, et al. Immune response and gene polymorphism profiles in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2009; 15: 353-8.
104. Julia A, Tortosa R, Hernanz JM, Canete JD, Fonseca E, Ferrandiz C, et al. Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes. Hum Mol Genet. 2012; 21: 4549-57.
105. Zhang X, Xia P, Zhang L, Zhang Z. Upregulation of tumor necrosis factor alpha-induced protein 3 mRNA in mild psoriasis vulgaris. Clin Vaccine Immunol. 2013; 20: 1341.
106. Gümüş P, Nizam N, Lappin DF, Buduneli N. Saliva and serum levels of B-cell activating factors and tumor necrosis factoralpha in patients with periodontitis. J Periodontol. 2014; 85: 270-80.
107. Conner HD, Haberman S, Collings CK, Winford TE. Bacteremias following periodontal scaling in patients with healthy appearing Gingiva. J Periodontol. 1967; 38: 466-72.
108. Daly C, Mitchell D, Grossberg D, Highfield J, Stewart D. Bacteraemia caused by periodontal probing. Aust Dent J. 1997; 42: 77-80.
109. Hill GB. Preterm birth: associations with gential and possibly oral microflora. Ann Periodontol. 1998; 3: 222-32.
110. Goldenberg RL, Hauth JC, Andrews WW. Mechanisms of disease-intrauterine infection and preterm delivery. N Engl J Med. 2000; 342: 1500-7.
111. Gonzales-Marin C, Spratt DA, Allaker RP. Maternal oral origin of Fusobacterium nucleatum in adverse pregnancy outcomes as determined using the 16S-23S rRNA gene intergenic transcribed spacer region. J Med Microbiol. 2013; 62: 133-44.
112. O'Boyle CJ, MacFie J, Dave K, Sagar PS, Poon P, Mitchell CJ. Alterations in intestinal barrier function do not predispose to translocation of enteric bacteria in gastroenterologic patients. Nutrition. 1998; 14: 358-62.
113. Shanahan F. The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol. 2002; 16: 915-31.
114. Naaber P, Smidt I, Tamme K, Liigant A, Tapfer H, Mikelsaar M, et al. Translocation of indigenous microflora in an experimental model of sepsis. J Med Microbiol. 2000; 49: 431-9.